David Mutimer

1.1k total citations
23 papers, 623 citations indexed

About

David Mutimer is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, David Mutimer has authored 23 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 17 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in David Mutimer's work include Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). David Mutimer is often cited by papers focused on Hepatitis C virus research (17 papers), Hepatitis B Virus Studies (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). David Mutimer collaborates with scholars based in United Kingdom, United States and Germany. David Mutimer's co-authors include Paul Gow, M Wali, Rebecca Harrison, Alonso Vera, Peter Stärkel, Bridget Gunson, Jean Shaw, Marco Carbone, James Neuberger and Amar P. Dhillon and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

David Mutimer

23 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Mutimer United Kingdom 10 499 472 146 62 50 23 623
Yaffa Ashur Israel 15 470 0.9× 454 1.0× 90 0.6× 85 1.4× 15 0.3× 38 657
John P. Roberts United States 9 652 1.3× 487 1.0× 412 2.8× 26 0.4× 49 1.0× 12 840
Nancy L. Ascher United States 8 834 1.7× 689 1.5× 200 1.4× 41 0.7× 25 0.5× 9 924
E. Murio Spain 13 271 0.5× 195 0.4× 255 1.7× 19 0.3× 34 0.7× 32 448
Sergio Rodríguez‐Tajes Spain 15 697 1.4× 660 1.4× 64 0.4× 96 1.5× 17 0.3× 48 879
N.V. Naoumov United Kingdom 10 702 1.4× 615 1.3× 80 0.5× 48 0.8× 11 0.2× 18 755
Cheng‐Chao Liang Taiwan 13 565 1.1× 521 1.1× 57 0.4× 56 0.9× 16 0.3× 23 647
Alonso Vera Colombia 8 328 0.7× 215 0.5× 277 1.9× 33 0.5× 157 3.1× 17 483
S. Pol France 11 571 1.1× 474 1.0× 44 0.3× 99 1.6× 16 0.3× 54 660
Deborah Weppler United States 14 270 0.5× 254 0.5× 324 2.2× 71 1.1× 39 0.8× 31 681

Countries citing papers authored by David Mutimer

Since Specialization
Citations

This map shows the geographic impact of David Mutimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mutimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mutimer more than expected).

Fields of papers citing papers by David Mutimer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Mutimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mutimer. The network helps show where David Mutimer may publish in the future.

Co-authorship network of co-authors of David Mutimer

This figure shows the co-authorship network connecting the top 25 collaborators of David Mutimer. A scholar is included among the top collaborators of David Mutimer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Mutimer. David Mutimer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zamor, Philippe J., Ashley Brown, Douglas E. Dylla, et al.. (2021). High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence. The American Journal of Gastroenterology. 116(9). 1896–1904. 8 indexed citations
2.
Bradshaw, Daniel, Jean L. Mbisa, Anna María Geretti, et al.. (2019). Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group. Journal of Infection. 79(6). 503–512. 13 indexed citations
3.
Lim, Young-Suk, David Mutimer, Jeong Heo, et al.. (2019). PS-078-A phase 1b evaluation of HepTcell HBV-specific immunotherapy in nuc-controlled, eAg negative chronic HBV infection. Journal of Hepatology. 70(1). e50–e51. 16 indexed citations
4.
5.
Krishnamoorthy, Thinesh Lee & David Mutimer. (2015). Hepatitis B. Current Opinion in Infectious Diseases. 28(6). 557–562. 5 indexed citations
6.
7.
8.
Carbone, Marco, David Mutimer, & James Neuberger. (2012). Hepatitis C Virus and Nonliver Solid Organ Transplantation. Transplantation. 95(6). 779–786. 35 indexed citations
9.
10.
Thurairajah, Prem Harichander, Douglas Thorburn, S.G. Hübscher, et al.. (2007). Incidence and characterization of serum transaminases elevations in pegylated interferon and ribavirin treated patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 25(11). 1293–1300. 18 indexed citations
11.
Wali, M, Rebecca Harrison, Paul Gow, & David Mutimer. (2007). C progression following transplantation for hepatitis Advancing donor liver age and rapid fibrosis. 1 indexed citations
12.
Zhang, Wanxing, et al.. (2006). Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants.. PubMed. 5(1). 154–6. 2 indexed citations
13.
Wali, M, Rebecca Harrison, Paul Gow, & David Mutimer. (2002). Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut. 51(2). 248–252. 219 indexed citations
14.
Stärkel, Peter, Alonso Vera, Bridget Gunson, & David Mutimer. (2002). Outcome of liver transplantation for patients with pulmonary hypertension. Liver Transplantation. 8(4). 382–388. 67 indexed citations
15.
Annemans, Lieven, K Moeremans, David Mutimer, et al.. (2002). Modeling Costs and Cost-Effectiveness of Different CMV Management Strategies in Liver Transplant Recipients as a Support for Current and Future Decision Making. Value in Health. 5(4). 347–358. 8 indexed citations
16.
Gow, Paul & David Mutimer. (2000). Mechanisms of hepatitis B virus escape after immunoglobulin therapy. Current Opinion in Infectious Diseases. 13(6). 643–646. 5 indexed citations
17.
Mutimer, David, Geoffrey Dusheiko, Catherine Barrett, et al.. (2000). LAMIVUDINE WITHOUT HBIg FOR PREVENTION OF GRAFT REINFECTION BY HEPATITIS B: LONG-TERM FOLLOW-UP. Transplantation. 70(5). 809–815. 112 indexed citations
18.
Mutimer, David, Narinder Kaur, Howard Tang, et al.. (2000). QUANTITATION OF EPSTEIN-BARR VIRUS DNA IN THE BLOOD OF ADULT LIVER TRANSPLANT RECIPIENTS1. Transplantation. 69(5). 954–959. 29 indexed citations
19.
Mutimer, David, Darius F. Mirza, Jean Shaw, Katharina O'Donnell, & Elwyn Elias. (1997). ENHANCED (CYTOMEGALOVIRUS) VIRAL REPLICATION ASSOCIATED WITH SEPTIC BACTERIAL COMPLICATIONS IN LIVER TRANSPLANT RECIPIENTS. Transplantation. 63(10). 1411–1415. 47 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaffa Ashur Breakdown of academic impact, for papers by John P. Roberts Breakdown of academic impact, for papers by Nancy L. Ascher Breakdown of academic impact, for papers by E. Murio Breakdown of academic impact, for papers by Sergio Rodríguez‐Tajes Breakdown of academic impact, for papers by N.V. Naoumov Breakdown of academic impact, for papers by Cheng‐Chao Liang Breakdown of academic impact, for papers by Alonso Vera Breakdown of academic impact, for papers by S. Pol Breakdown of academic impact, for papers by Deborah Weppler
Rankless by CCL
2026